• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Morgan Stanley Ins Muni Secs

Morgan Stanley Ins Muni Secs

  1. All
  2. 3rd Party
  1. FDA Approves Symbiomix Therapeutics’ Solosec™ (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women

    FDA Approves Symbiomix Therapeutics’ Solosec™ (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women

  2. QuintilesIMS Announces Offering of Senior Notes, Redemption of Existing Euro Senior Notes and Proposed Amendment to Senior Secured Credit Facility

    QuintilesIMS Announces Offering of Senior Notes, Redemption of Existing Euro Senior Notes and Proposed Amendment to Senior Secured Credit Facility

  3. QuintilesIMS Announces Pricing on Offering of Senior Notes

    QuintilesIMS Announces Pricing on Offering of Senior Notes

  4. QuintilesIMS Announces Launch of Secondary Public Offering and Repurchase of Common Stock

    QuintilesIMS Announces Launch of Secondary Public Offering and Repurchase of Common Stock

  5. Sequans Powers Geotab’s New GO8 LTE Telematics Device

    Sequans Powers Geotab’s New GO8 LTE Telematics Device

  6. Alvogen Subsidiary Confirms ANDA Filing and Patent Challenge for Generic Revlimid®

    Alvogen Subsidiary Confirms ANDA Filing and Patent Challenge for Generic Revlimid®

  7. Dr. Reddy's Laboratories Announces the Launch of Metaxalone Tablets, USP in the U.S. Market

    Dr. Reddy's Laboratories Announces the Launch of Metaxalone Tablets, USP in the U.S. Market

  8. Dr. Reddy's Laboratories Announces the Launch of Bupropion Hydrochloride Extended-Release Tablets, USP (XL) in the U.S. Market

    Dr. Reddy's Laboratories Announces the Launch of Bupropion Hydrochloride Extended-Release Tablets, USP (XL) in the U.S. Market

  9. Mobile World Congress Americas 2017 Exhibitor Profiles

    Mobile World Congress Americas 2017 Exhibitor Profiles

  10. Central Garden & Pet Announces Vendor Awards for 2017

    Central Garden & Pet Announces Vendor Awards for 2017

12345

©2017 Morningstar Advisor. All right reserved.